Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

 

Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity
C

Hematologic irAEs Seen With ICls: Pathophysiology, Demographics, Distribution, Management Guidelines, the Most Common Entities

By Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Christy Samaras
By Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity FEATURING Christy Samaras
5 views
March 19, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay
Videos
05:12
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

70 y/o Male With Uveal Melanoma Treated With Ipi + Nivo: Guidelines …

Feat. A. Fernandez
15:26
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

mRCC Case Study Panel Discussion: Management of Long-Term CPI irAEs …

Feat. A. Haddad, J. Ellsworth-Wolk, C. Calabrese
09:46
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Long Term irAEs & Long Term Steroid Use in Cancer Patients: Chal…

Feat. C. Calabrese
09:42
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Long Term Sequelae & Survivorship in Cancer Patients: The System…

Feat. J. Ellsworth-Wolk
10:04
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

68 y/o Male With HCC Presented With IVCC Tumor Thrombus: Recommendat…

Feat. B. Estfan, M. McGinley, J. Philpott, C. Lindenmeyer
06:18
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

72 y/o Right Handed Male With Metastatic Melanoma Underwent Treatmen…

Feat. B. Estfan, M. McGinley, J. Philpott, C. Lindenmeyer
10:53
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Hepatic Immune-Related Adverse Events: ICI-Related Hepatitis, Diagno…

Feat. C. Lindenmeyer
13:25
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Adverse Intestinal Effects of Immunotherapy for Cancer: Colitis Epid…

Feat. J. Philpott
10:36
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Neurologic Complications of Immune Checkpoint Inhibitors: Incidence,…

Feat. M. McGinley
07:51
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

51 y/o With Stage IIIA Lung Adenocarcinoma Presented to the ICU With…

Feat. P. Patil, R. Moudgil, N. Thiruchelvam, S. Mucha
06:35
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

82 y/o Woman With Recurrent Endometrial Adenocarcinoma Treated With …

Feat. P. Patil, R. Moudgil, N. Thiruchelvam, S. Mucha
07:16
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

52 y/o Male Diagnosed With cHL Presented With SOB, Cough, Dyspnea &a…

Feat. P. Patil, R. Moudgil, N. Thiruchelvam, S. Mucha
07:18
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

2021 Update on Management of irAEs in the ICU: Incidence, Clinical P…

Feat. S. Mucha
10:46
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

2021 Update on Pulmonary Immune-Related Adverse Events: Prevalence &…

Feat. N. Thiruchelvam
10:02
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Management of Checkpoint Inhibitor-Mediated Adverse Cardiac Events: …

Feat. R. Moudgil
08:27
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

68 y/o Male With H&N Cancer Metastasized to Liver & Lungs Tr…

Feat. J. Geiger, C. Samaras, A. Mehdi, s. srivastava
08:00
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Tricky Checkpoint Inhibitors-Related irAEs: 64 y/o Male With Metasta…

Feat. J. Geiger, C. Samaras, A. Mehdi, s. srivastava
10:46
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Diagnosis & Management of Ophthalmic Complications of CPIs: How …

Feat. s. srivastava
11:53
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

The Kidneys & Immune Checkpoint Inhibitors: Incidence of CPI-Ass…

Feat. A. Mehdi
12:42
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Hematologic irAEs Seen With ICls: Pathophysiology, Demographics, Dis…

Feat. C. Samaras
11:46
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

56 y/o Male w/ Stage 4 RCC Being Managed for CPI-Related Inflammator…

Feat. M. Ornstein, L. Calabrese, C. Calabrese
05:06
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

81 y/o Male With RA and Stage IV Melanoma: What Is the Optimal Manag…

Feat. M. Ornstein, L. Calabrese, C. Calabrese
10:34
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Rheumatic Immune-Related AEs From CPI Therapy: When to Consider Rheu…

Feat. C. Calabrese
16:58
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Lessons Learned From irAE Management During COVID-19: Cytokine Storm…

Feat. L. Calabrese
11:08
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

72 y/o Male With RCC Treated With Pembro: How to Manage CPI-Related …

Feat. J. Stevenson, C. Nasr
10:32
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Endocrine Immune-Related Adverse Events: How Important Is Monitoring…

Feat. C. Nasr
10:02
Cleveland Clinic's 2021 Management of Checkpoint Inhibitor-Related Toxicity

Cutaneous ICI-Related Adverse Events: Which Ones Are the Most Common…

Feat. A. Fernandez